Agape ATP Corporation (NASDAQ:ATPC – Get Free Report) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 9,771 shares, a decline of 57.5% from the September 15th total of 23,016 shares. Approximately 1.0% of the company’s shares are sold short. Based on an average daily volume of 22,972 shares, the days-to-cover ratio is presently 0.4 days.
Analyst Ratings Changes
Several research analysts have recently commented on ATPC shares. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research report on Monday, June 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agape ATP in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Agape ATP currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Report on Agape ATP
Agape ATP Stock Down 8.5%
Agape ATP (NASDAQ:ATPC – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported $0.15 earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter. Agape ATP had a negative net margin of 85.94% and a negative return on equity of 5.47%.
About Agape ATP
Agape ATP Corporation (NASDAQ: ATPC) is a Malaysia-based health and wellness company focused on products and services intended to support healthy aging and overall well-being. The company operates through a direct-selling and distribution model.
Its offerings include nutritional supplements, wellness products and related health-focused services. Agape ATP has also promoted personalized wellness programs and products associated with preventive health and anti-aging. The company primarily serves customers in Malaysia and has described its business as having an international focus across parts of Asia.
Agape ATP Corporation is headquartered in Malaysia and is publicly traded on the Nasdaq Stock Market.
Featured Stories
- Five stocks we like better than Agape ATP
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
- Flex’s AI Infrastructure Spin-Off Could Unlock Hidden Value
- A Silent Winner: Texas Instruments Anchors the AI Supercycle
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
